SSTR2 and small cell lung carcinoma: Interestingly, somatostatin receptor 2 (SSTR2) upregulation is also associated with NEUROD1 expression in both SCLC cell lines and primary tumors, and correlates with worse clinical outcomes (Lehman et al., 2019; Gay et al., 2021).